Fredun Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/02/2026 ,inter alia, to consider and approve Intimation is hereby ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Fredun Pharmaceuticals has informed BSE that its Board of Directors will meet on Monday, 9th February 2026. The main item on the agenda is to consider and approve the un-audited standalone and consolidated financial results for the third quarter and nine months ended 31st December 2025. As per insider trading rules, the trading window for the company's shares will remain closed for directors, officers, KMPs, and designated employees until 48 hours after the results are declared. This is a routine regulatory filing ahead of the earnings announcement.
No direct impact on shareholders at this stage — investors should watch for the actual Q3 FY26 results on or after 9th February 2026, which will contain the key revenue, profit, and margin numbers. The closed trading window also means insiders cannot trade in the stock until results are out.